EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade



Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade



American Journal of Cardiology 59(6): 573-577



Previous studies indicate that programmed extrastimulus testing (PES) during isoproterenol infusion facilitates induction of clinical ventricular tachycardia (VT) in some patients. This study attempts to determine if VT inducible only during isoproterenol infusion predicts suppression of VT with chronic oral beta-adrenergic blockade. Nine patients, aged 23 to 77 years, with symptomatic VT or syncope not necessarily provoked by exercise or stress were evaluated. Extrastimuli did not induce VT in any patient. However, during isoproterenol infusion (1 to 4 micrograms/min), all patients had reproducibly inducible VT corresponding to their spontaneously occurring VT (recordings available in 7 patients). Coupling intervals inducing tachycardia during isoproterenol were similar to intervals that did not induce VT without isoproterenol. No patient had VT with isoproterenol infusion alone (without extrastimuli). In only 4 of 8 patients who underwent exercise tests while not taking medications was VT provoked. With propranolol therapy (160 mg/day) or its equivalent, only 1 patient had recurrent symptoms during a mean follow-up of 39 months (range 23 to 52). VT inducible with extrastimuli only during isoproterenol infusion predicts that oral beta-adrenergic blockade will prevent spontaneous VT or syncope long term. These data suggest that occurrence of VT in some patients depends on premature depolarizations in the setting of beta-adrenergic influence.

(PDF emailed within 0-6 h: $19.90)

Accession: 041927739

Download citation: RISBibTeXText

PMID: 2881479

DOI: 10.1016/0002-9149(87)91172-6



Related references

The role of beta-blockade therapy for ventricular tachycardia induced with isoproterenol: a prospective analysis. American Heart Journal 120(6 Pt 1): 1347-1355, 1990

Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study. Acta Cardiologica 52(1): 67-74, 1997

Usefulness of a ventricular extrastimulus from the summit of the ventricular septum in diagnosis of septal accessory pathway in patients with supraventricular tachycardia. American Journal of Cardiology 93(5): 643-646, 2004

Reproducible termination of ventricular tachycardia by a single extrastimulus within the reentry circuit during the ventricular effective refractory period. American Heart Journal 116(2 Pt 1): 546-550, 1988

Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure. Journal of Cardiac Failure 2(4): 311-318, 1996

Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pacing and Clinical Electrophysiology 19(7): 1026-1035, 1996

Prevention of ventricular tachycardia induction by introduction of a second extrastimulus. American Journal of Cardiology 57(10): 881-882, 1986

Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. American Journal of Cardiology 44(4): 705-713, 1979

Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome. Journal of Cardiovascular Pharmacology 36 Suppl 2: S79-S82, 2001

Beta-Adrenergic Blockade Therapy for Autonomic Dysfunction is Less Effective for Elderly Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction. Japanese Clinical Medicine 6(): 21-27, 2015

Induction of ventricular tachycardia with the fourth extrastimulus and its relationship to risk of arrhythmic events in patients with post-myocardial infarct left ventricular dysfunction. Europace 14(12): 1771-1777, 2013

Effects of beta adrenergic blockade on the cardiovascular responses to ventricular tachycardia. Acta Cardiologica 21(4): 477-483, 1966

Hemodynamics of dopamine and isoproterenol in chronic canine beta adrenergic blockade. Bulletin of the New York Academy of Medicine 55(4): 406, 1979

Inotropism without chrono tropism in response to isoproterenol after combined beta adrenergic blockade and alpha adrenergic blockade in man. Circulation Supplement 54(2): II-71, 1976

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia. Circulation 32(5): 778-781, 1965